Literature DB >> 16775612

Endothelial dysfunction in diabetic erectile dysfunction.

B Musicki1, A L Burnett.   

Abstract

Erectile dysfunction (ED) is highly prevalent in diabetes mellitus. Pathophysiological mechanisms underlying diabetes-associated ED are in large part due to endothelial dysfunction, which functionally refers to the inability of the endothelium to produce vasorelaxing messengers and to maintain vasodilation and vascular homeostasis. The precise mechanisms leading to endothelial dysfunction in the diabetic vasculature, including the penis, are not yet fully understood. Hyperglycemia affects endothelial nitric oxide synthase activity and nitric oxide production/bioavailability, nitric oxide-independent relaxing factors, oxidative stress, production and/or action of hormones, growth factors and/or cytokines, and generation and activity of opposing vasoconstrictors. Considering recent advances in the field of vascular biology and diabetes, the emphasis in this review is placed on the mechanisms of hyperglycemia-induced endothelial dysfunction in the pathophysiology of diabetes-associated ED.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16775612     DOI: 10.1038/sj.ijir.3901494

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  45 in total

Review 1.  cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.

Authors:  Sharron H Francis; Jennifer L Busch; Jackie D Corbin; David Sibley
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

2.  Pim1 kinase promotes angiogenesis through phosphorylation of endothelial nitric oxide synthase at Ser-633.

Authors:  Ming Chen; Bing Yi; Ni Zhu; Xin Wei; Guan-Xin Zhang; Shengdong Huang; Jianxin Sun
Journal:  Cardiovasc Res       Date:  2015-11-23       Impact factor: 10.787

3.  Early-stage Type 2 Diabetes Mellitus Impairs Erectile Function and Neurite Outgrowth From the Major Pelvic Ganglion and Downregulates the Gene Expression of Neurotrophic Factors.

Authors:  Hotaka Matsui; Biljana Musicki; Nikolai A Sopko; Xiaopu Liu; Paula J Hurley; Arthur L Burnett; Trinity J Bivalacqua; Johanna L Hannan
Journal:  Urology       Date:  2016-09-14       Impact factor: 2.649

4.  Constitutive NOS uncoupling and NADPH oxidase upregulation in the penis of type 2 diabetic men with erectile dysfunction.

Authors:  B Musicki; A L Burnett
Journal:  Andrology       Date:  2017-01-11       Impact factor: 3.842

Review 5.  Understanding and targeting the Rho kinase pathway in erectile dysfunction.

Authors:  Nikolai A Sopko; Johanna L Hannan; Trinity J Bivalacqua
Journal:  Nat Rev Urol       Date:  2014-10-14       Impact factor: 14.432

6.  Arginase II deletion increases corpora cavernosa relaxation in diabetic mice.

Authors:  Haroldo A Toque; Rita C Tostes; Lin Yao; Zhimin Xu; R Clinton Webb; Ruth B Caldwell; R William Caldwell
Journal:  J Sex Med       Date:  2010-11-03       Impact factor: 3.802

7.  Mechanistic link between erectile dysfunction and systemic endothelial dysfunction in type 2 diabetic rats.

Authors:  B Musicki; J L Hannan; G Lagoda; T J Bivalacqua; A L Burnett
Journal:  Andrology       Date:  2016-05-06       Impact factor: 3.842

Review 8.  Molecular mechanisms associated with diabetic endothelial-erectile dysfunction.

Authors:  Ângela Castela; Carla Costa
Journal:  Nat Rev Urol       Date:  2016-02-16       Impact factor: 14.432

9.  Pharmacokinetic interaction between DA-8159, a new erectogenic, and metformin in rats: competitive inhibition of metabolism via hepatic CYP3A1/2.

Authors:  Y H Choi; S J Chung; M G Lee
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

Review 10.  Cigarette smoking and erectile dysfunction: focus on NO bioavailability and ROS generation.

Authors:  Rita C Tostes; Fernando S Carneiro; Anthony J Lee; Fernanda R C Giachini; Romulo Leite; Yoichi Osawa; R Clinton Webb
Journal:  J Sex Med       Date:  2008-03-04       Impact factor: 3.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.